FREEHOLD, NJ--(Marketwire - Feb 14, 2012) - United Health Products, Inc. (OTCQB: [ UEEC ]) (PINKSHEETS: [ UEEC ]) which develops and markets products and technologies in the healthcare sector, today announced that its hemostatic gauze (Hemostyp™) will be included in Diabetic Emergency Kits produced by Essential Preparedness Products - EPP. EPP's Diabetic Ecase ("Ecase") [ www.epp-ecase.com ] is designed to assist diabetics who face an emergency situation that allows medications and products essential for their daily life support to be stored safely until needed. The Ecase is offered in two configurations to meet the various types of diabetic conditions that users may have. Diabetes is one of the fastest growing health concerns in the world with over 28 million diabetics in the US alone. EPP's Ecase will be available with numerous online pharmacies and emergency kit providers. EPP is also negotiating with several major retailers and pharmacies in the US and Canada to carry this product. EPP's website will post where the product is available to be purchased when the information is released.

About United Health Products, Inc.
United Health Products, Inc. (UEEC) develops, manufactures and markets products and technologies in the healthcare sector. UEEC's operating subsidiary Epic Wound Care, Inc. produces hemostatic gauze, derived from regenerated oxidized cellulose, which is all natural and designed to absorb exudate/drainage from superficial wounds. UEEC is focused on identifying emerging healthcare products and technologies for strategic partnership or acquisition.

Safe Harbor Statement
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements.